Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Vedolizumab (Entyvio TM) is approved by both the FDA and EMA for the treatment of Crohn's disease (CD) in adults with moderately to severely active disease.
Vedolizumab, an Integrin alfa-4-beta-7 inhibitor, is effective, well-tolerated, and safe for long-term use in Crohn's disease (CD) patients. Vedolizumab can heal mucosa and change disease progression, supporting its use as a first-line biologic early in Crohn's disease (CD). Conce…